BioRestorative Therapies Inc

NASDAQ BRTX

Data sourced from iex and EODHD
Download Data

BioRestorative Therapies Inc Income Statement 2009 - 2024

This table shows the Income Statement for BioRestorative Therapies Inc going from 2009 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31
Revenue
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - -
Cost of Revenue
M 0 0 - - - - - - - - - - - - - - - 0 1 3 5 7 7 8 8 7 7 4 2 2 0 0 0 0 0 0 0 1 1 1 1 2 2 3 4 3 3 1 - - - - - - - - -
Gross Profit
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - -
Operating Expenses
M 9 17 18 20 19 18 17 16 12 10 7 4 3 1 2 4 6 9 8 8 7 7 7 8 8 9 9 8 8 9 9 8 8 6 5 5 5 4 4 3 4 4 4 4 3 3 1 - - - - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 7 13 14 16 16 15 15 15 11 9 6 3 3 3 4 5 7 6 6 6 5 5 6 6 6 6 6 5 5 6 6 5 5 4 4 4 3 3 3 2 3 3 3 4 3 4 3 3 3 4 4 3 2 1 1 0 0
Research and Development (R&D) Expenses
M 3 4 4 4 4 3 2 1 1 1 1 1 1 1 1 1 2 2 2 2 1 1 1 2 2 3 3 3 3 3 3 3 2 2 2 1 1 1 2 2 1 1 1 1 1 0 0 0 0 - - 0 0 0 0 - -
Other Operating Expenses
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - -
Costs and Expenses
M 9 16 - - - - - - - - - - - - - - - 2 2 2 2 0 0 0 0 2 2 4 6 7 9 8 7 6 5 5 5 4 4 3 4 4 4 3 1 1 -1 -1 - - - - - - - - -
Operating Income
M -9 -17 -18 -20 -19 -18 -17 -16 -12 -10 -7 -4 -4 -4 -5 -7 -8 -8 -8 -8 -7 -6 -7 -7 -8 -9 -9 -8 -8 -9 -8 -8 -7 -6 -5 -5 -5 -3 -4 -3 -4 -4 -4 -4 -3 -3 -3 -3 -3 -4 -4 -3 -2 0 - - -
Interest Expense
M 0 0 0 0 0 0 1 1 1 2 1 1 5 8 10 11 8 5 4 4 3 3 2 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0
Non-operating Income/Expense
M 3 3 0 0 0 0 -1 -1 2 4 4 8 2 2 1 -3 -1 -3 -3 -2 -2 -1 0 0 0 0 0 0 0 -1 -1 -1 0 0 0 0 -1 0 0 -1 0 0 0 0 -1 -1 -1 -1 0 -1 0 0 0 0 - - -
EBT
M -6 -13 -18 -19 -18 -35 -34 -33 -26 -7 -3 4 -7 -7 -11 -18 -15 -17 -15 -14 -12 -10 -9 -9 -9 -10 -9 -9 -9 -10 -9 -9 -8 -6 -6 -6 -7 -5 -6 -5 -4 -4 -5 -5 -5 -5 -4 -4 -3 -5 -4 -3 -2 0 - - -
Income Tax Provision
M 0 -1 -1 -1 -1 0 0 0 0 1 1 1 1 - 1 1 2 2 2 2 2 2 2 1 1 1 1 1 1 0 0 0 0 0 0 0 -1 -1 -1 -1 0 0 0 0 -1 -1 -1 -1 0 0 0 0 0 0 - - -
Income after Tax
M -6 -12 -17 -19 -18 -35 -30 -25 -18 0 0 0 -3 - -6 -11 -15 -18 -16 -16 -14 -12 -11 -9 -10 -11 -10 -10 -9 -10 -10 -9 -8 -7 -6 -6 -6 -4 -5 -4 -5 -5 -5 -6 -4 -4 -3 -2 -2 -4 -4 -3 -2 0 - - -
Non-Controlling Interest
M 0 -3 -3 -3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Net Income
M -3 -10 -15 -17 -18 -35 -34 -33 -44 -31 -28 -21 -13 -6 -10 -17 -13 -17 -15 -14 -13 -11 -10 -9 -9 -10 -8 -5 -2 - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 4,388,023.00 3,960,440.25 3,715,963.50 3,653,982.00 3,605,414.50 2,919,002.75 2,226,501.75 1,526,142.00 745,007.00 626,619.75 399,071,412.75 797,525,022.50 1,196,088,202.75 1,215,451,445.50 816,790,082.00 418,128,473.25 19,466,548.25 4,560.75 3,623.50 2,808.00 2,292.25 1,186,446.50 1,186,251.75 1,186,173.25 1,186,101.25 1,359.25 1,286.25 1,202.25 1,114.75 1,027.25 928.25 843.50 714.00 584.50 503.00 406.75 358.75 323.67 265.67 231.33 209.00 209.00 195.33 181.67 165.33 165.33 155.67 146.00 140.33 140.00 371.75 449.33 604.50 1,070.00 - - -
EBITDA
M -9 -17 -18 -20 -19 -34 -33 -32 -28 -9 -6 0 -3 -1 -4 -9 -8 -12 -10 -9 -8 -5 -5 -6 -7 -9 -8 -8 -8 -8 -8 -7 -7 -6 -5 -5 -5 -4 -4 -4 -4 -4 -4 -4 -3 -3 -3 -2 -3 -4 -3 -2 -1 0 - - -
Depreciation and Amortization
M 0 0 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - -
EBIT
M -9 -17 -18 -20 -19 -34 -34 -32 -28 -9 -6 0 -3 2 -1 -7 -6 -12 -10 -10 -8 -7 -7 -7 -8 -9 -9 -8 -8 -9 -8 -8 -7 -6 -5 -5 -5 -4 -4 -4 -4 -4 -4 -4 -3 -3 -3 -2 -3 -4 -3 -2 -1 0 - - -
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% 17.93 16.81 3.92 2.86 3.76 0.47 0.96 1.94 -0.10 -41.59 -41.59 -41.59 -84.02 - -11.70 -15.08 -15.30 -9.07 -10.23 -14.63 -16.11 -18.51 -17.77 -10.41 -6.51 -13.46 -10.90 -9.75 -8.67 -2.18 -2.64 -3.20 -3.68 -4.31 -4.77 -5.07 6.95 10.73 8.54 9.50 -7.53 -7.53 -6.97 -9.44 12.02 12.02 23.87 26.41 -3.54 -3.24 -3.70 -3.31 -3.87 -5.08 - - -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Gross Profit Margin
% -55.98 -724.92 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 99.91 99.91 99.80 99.78 92.39 79.15 66.71 56.41 30.87 33.78 40.30 46.64 72.86 83.97 89.18 91.12 91.12 85.69 88.51 87.85 87.85 100.00 - - - - - - - - - -
Operating Income Margin
% -10,543.84 -39,986.39 -41,432.22 -41,851.77 -45,132.42 -33,544.27 -41,097.54 -45,395.47 -38,106.27 -19,744.21 -9,234.17 -3,916.09 -4,096.22 -4,096.22 -4,275.82 -5,385.25 -6,604.94 -6,798.18 -6,744.42 -6,413.01 -5,440.20 -4,597.08 -6,178.56 -8,004.47 -15,860.69 -22,529.05 -28,380.68 -28,485.94 -25,258.71 -17,906.47 -9,717.91 -6,613.59 -1,170.05 -1,232.29 -984.85 -954.72 -81,388.81 -107,968.11 -408,848.57 -495,968.76 -539,547.85 -539,547.85 -246,169.22 -163,449.04 -18,497.04 -18,497.04 -13,928.40 - - - - - - - - - -
Net Income Margin
% -4,621.01 -43,881.66 -36,924.89 -37,413.53 -42,558.13 -115,198.46 -124,260.55 -129,387.64 -142,458.89 -46,342.24 -34,660.29 -24,105.54 -10,769.41 -6,493.82 -9,071.40 -18,586.51 -13,369.45 -13,105.07 -12,590.87 -11,612.91 -9,915.12 -8,060.58 -8,454.21 -9,513.58 -17,812.93 -25,053.15 -29,129.02 -36,825.58 -33,854.67 - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EBITDA Ratio
% -10,448.61 -40,662.23 -42,096.05 -42,520.60 -45,766.03 -114,247.31 -121,745.17 -126,017.79 -118,760.14 -19,229.23 -9,049.82 689.90 -2,174.82 -1,155.47 -2,127.20 -10,087.17 -8,635.76 -9,194.40 -8,577.21 -7,832.41 -6,476.23 -5,011.54 -6,651.32 -8,989.37 -19,506.48 -22,253.99 -27,880.60 -27,968.84 -24,581.22 -17,299.65 -9,422.87 -6,410.44 -1,132.48 -1,195.49 -960.26 -935.01 -99,111.39 -131,607.74 -394,112.08 -479,168.70 -496,625.29 -496,625.29 -241,455.43 -160,769.00 -18,186.88 -18,186.88 -13,824.95 - - - - - - - - - -
EBIT Ratio
% -10,589.60 -40,020.71 -41,432.22 -41,851.77 -45,132.42 -114,444.55 -121,997.82 -126,295.75 -119,006.55 -19,411.87 -8,596.18 1,144.82 -1,684.79 1,702.05 367.71 -5,609.88 -4,566.72 -9,368.61 -8,773.82 -8,027.53 -6,668.10 -4,935.51 -6,208.93 -8,002.71 -16,078.01 -22,938.16 -28,789.79 -28,896.81 -25,450.50 -17,906.47 -9,717.91 -6,613.59 -1,170.05 -1,232.29 -984.85 -954.72 -100,842.21 -133,905.98 -403,327.77 -490,447.96 -508,089.19 -508,089.19 -246,169.22 -163,449.04 -18,497.04 -18,497.04 -13,928.40 - - - - - - - - - -
EBT Ratio
% -6,510.30 -35,138.58 -39,084.37 -39,573.01 -42,558.13 -115,198.46 -124,260.55 -129,387.64 -118,078.64 -17,274.32 -4,981.08 5,573.67 -5,470.45 -5,470.45 -8,014.92 -15,151.26 -11,238.46 -13,105.07 -12,590.87 -11,612.91 -9,488.78 -7,634.24 -8,027.88 -9,087.25 -17,812.93 -25,053.15 -31,016.16 -31,077.09 -27,942.57 -19,870.52 -11,123.46 -7,867.23 -1,290.61 -1,364.31 -1,114.00 -1,064.74 -196,426.83 -261,282.02 -608,521.46 -706,401.83 -621,343.04 -621,343.04 -283,297.49 -190,651.72 -22,365.63 -22,365.63 -16,461.51 - - - - - - - - - -

StockViz Staff

September 20, 2024

Any question? Send us an email